Search Results - "Linares, Luis Francisco"
-
1
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis
Published in Arthritis research & therapy (08-01-2019)“…The objective was to determine if dose reduction is non-inferior to full-dose TNFi to maintain low disease activity (LDA) in patients already in remission with…”
Get full text
Journal Article -
2
Standards of care for patients with spondyloarthritis
Published in Rheumatology international (01-02-2014)“…To define and give priory to standards of care in patients with spondyloarthritis (SpA). A systematic literature review on SpA standards of care and a specific…”
Get full text
Journal Article -
3
Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients
Published in Reumatologia clinica (01-09-2011)“…Due to the increasing use of biologic therapy in rheumatic diseases and the importance of its risk management, the Spanish Society of Rheumatology (SER) has…”
Get more information
Journal Article -
4
Diagnostic evaluation and classification criteria in Sjögren's Syndrome
Published in Joint, bone, spine : revue du rhumatisme (01-01-2009)“…Abstract Objectives Our objective is to carry out a clinical study of the performance of the preliminary European classification criteria for Sjögren Syndrome…”
Get full text
Journal Article -
5
Pelvic osteoid osteoma simulating sacroiliitis
Published in Reumatologia clinica (01-05-2016)Get more information
Journal Article -
6
Prevalence and characteristics associated with dactylitis in patients with early spondyloarthritis: results from the ESPeranza cohort
Published in Clinical and experimental rheumatology (01-09-2018)“…Dactylitis is a typical feature of psoriatic arthritis. However, dactylitis was included as a spondyloarthritis (SpA) feature for both (axial and peripheral)…”
Get full text
Journal Article -
7
Should over-treatment of axial spondyloarthritis with biologics remain a concern after the issue of the new ASAS criteria? Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides)
Published in Clinical and experimental rheumatology (01-11-2018)“…To study whether disease status at treatment initiation has changed after the issue of the ASAS classification criteria. REGISPONSERBIO registers patients with…”
Get full text
Journal Article -
8
Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?
Published in Clinical and experimental rheumatology (01-01-2016)“…To evaluate the efficacy of etoricoxib in patients with axial ankylosing spondyloarthritis (AS) refractory to traditional NSAIDs. This was an open label,…”
Get full text
Journal Article -
9
Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists
Published in Clinical and experimental rheumatology (01-11-2013)“…To test the reliability of the Berlin MRI scoring method and the effect of a calibration exercise on the score's reliability among untrained readers in MRI…”
Get full text
Journal Article -
10
Relationship between fecal calprotectin, anti-Saccharomyces cerevisiae antibodies and other markers of disease activity in patients with spondyloarthritis
Published in Reumatologia clinica (01-11-2019)“…To assess the relationship between the increase of fecal calprotectin, anti-Saccharomyces cerevisiae antibodies (ASCA) and disease markers in a group of…”
Get full text
Journal Article -
11
Relationship Between Fecal Calprotectin, Anti-Saccharomycescerevisiae Antibodies and Other Markers of Disease Activity in Patients With Spondyloarthritis
Published in Reumatología clinica (Barcelona) (01-11-2019)“…To assess the relationship between the increase of faecal calprotectin, anti-Saccharomyces cerevisiae antibodies (ASCA) and disease markers in a group of…”
Get full text
Journal Article -
12
-
13
Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis
Published in Reumatología clinica (Barcelona) (01-11-2018)“…OBJECTIVERecent data published on biological therapy in axial spondyloarthritis (axSpA) since the last publication of the recommendations of the Spanish…”
Get full text
Journal Article -
14
Diagnostic evaluation and classification criteria in Sjoegren's Syndrome
Published in Joint, bone, spine : revue du rhumatisme (01-01-2009)“…Our objective is to carry out a clinical study of the performance of the preliminary European classification criteria for Sjoegren Syndrome and that of the…”
Get full text
Journal Article -
15
Axial spondyloarthritis: can all be classified?
Published in Reumatologia clinica (01-01-2017)Get more information
Journal Article -
16
Axial Spondyloarthritis: Can All Be Classified?
Published in Reumatología clinica (Barcelona) (01-01-2017)Get full text
Journal Article -
17
Recommendations for the prescription of physical exercise for patients with spondyloarthritis
Published in Reumatologia clinica (01-03-2019)“…OBJECTIVETo develop expert-based recommendations on physical activity and exercise for patients with spondyloarthritis (SpA). METHODSTwo discussion groups, one…”
Get full text
Conference Proceeding -
18
Pelvic Osteoid Osteoma Simulating Sacroiliitis
Published in Reumatología clinica (Barcelona) (01-05-2016)Get full text
Journal Article -
19
Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis
Published in Reumatología clinica (Barcelona) (01-11-2018)“…Recent data published on biological therapy in axial spondyloarthritis (axSpA) since the last publication of the recommendations of the Spanish Society of…”
Get full text
Journal Article -
20
Relación de calprotectina fecal y anti saccharomyces antisacaromices con otros marcadores de actividad en pacientes con espondiloartritis
Published in Reumatología clinica (01-11-2019)“…Valorar la relación entre la calprotectina fecal, ASCA y marcadores de enfermedad en espondiloartritis (Spa). Se evaluaron pacientes ≥18años que cumplían…”
Get full text
Journal Article